arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

SI-BONE, Inc.

SIBN
$18.62 ▼ -0.19 (-1.01%) at close
Healthcare ·Surgical & Medical Instruments & Apparatus ·USSurgical & Medical Instruments & Apparatus
38 Visible periods
30 Metrics
Peer-ranked Benchmarks
Price Chart
33
Health
Poor
Bearish
auto_awesome

Analytical Summary

SI-BONE, Inc. faces fundamental challenges with weakness in Profit Margin (%) and Operating Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $828.2M
Dividend Yield —
Revenue Growth 15.2% ↗
Op. Margin -8.6% ↗
ROIC -1.7% ↗
FCF / Share $-0.02 ↗
Trailing P/E —
Price / Book 4.6x
FCF Yield —
Debt / Equity 0.20
info Valuation on last close. End-of-day price, Sep 23, 2026.

38-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$56.01M
↑ +15.2% —
Net Income Profit after all expenses
$-4.33M
↑ +33.8% —
Operating Margin Operating profit as % of sales
-8.6%
↑ +11.4% 14th
FCF / Share Free cash flow per share
$-0.02
↑ +77.9% —
Long-Term Debt Long-term obligations
$35.63M
— +0.1% —
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability ↑
16
Returns ↑
34
Financial Health →
52
Cash Quality ↓
39

Dividend History

Dividend / share · sourced from SEC filings
$0.00 Latest / share

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 10 years · 38 quarters